All Stories

  1. Long-Acting C-Terminal Peptide–Modified hGH (MOD-4023): Results of a Safety and Dose-Finding Study in GHD Children

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2017, Endocrine Society

    Oleg Malievsky, Zvi zadik